BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10788684)

  • 1. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.
    Langendijk H; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Wouters M
    Radiother Oncol; 2000 Apr; 55(1):19-25. PubMed ID: 10788684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy.
    Langendijk JA; Aaronson NK; ten Velde GP; de Jong JM; Muller MJ; Wouters EF
    Acta Oncol; 2000; 39(8):949-58. PubMed ID: 11207002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer.
    Ubels RJ; Mokhles S; Andrinopoulou ER; Braat C; van der Voort van Zyp NC; Aluwini S; Aerts JG; Nuyttens JJ
    Radiat Oncol; 2015 Apr; 10():98. PubMed ID: 25896787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Slotman BJ; Wouters EF
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):847-53. PubMed ID: 12095549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
    Ozturk A; Sarihan S; Ercan I; Karadag M
    Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life assessment as a predictor of survival in non-small cell lung cancer.
    Braun DP; Gupta D; Staren ED
    BMC Cancer; 2011 Aug; 11():353. PubMed ID: 21843358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.
    Movsas B; Moughan J; Sarna L; Langer C; Werner-Wasik M; Nicolaou N; Komaki R; Machtay M; Wasserman T; Bruner DW
    J Clin Oncol; 2009 Dec; 27(34):5816-22. PubMed ID: 19858383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life assessment in advanced non-small-cell lung cancer patients undergoing an accelerated radiotherapy regimen: report of ECOG study 4593. Eastern Cooperative Oncology Group.
    Auchter RM; Scholtens D; Adak S; Wagner H; Cella DF; Mehta MP
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1199-206. PubMed ID: 11483329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Lamers RJ; Slotman BJ; Wouters EF
    J Clin Oncol; 2001 Apr; 19(8):2123-33. PubMed ID: 11304764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy.
    Mathieu D; Campeau MP; Bahig H; Larrivée S; Vu T; Lambert L; Lavoie C; Roberge D; Doucet R; Carrier JF; Gorgos A; Fortin B; Filion E
    Pract Radiat Oncol; 2015; 5(4):e365-73. PubMed ID: 25680997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
    Nguyen LN; Komaki R; Allen P; Schea RA; Milas L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1053-6. PubMed ID: 10421538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
    Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
    JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study.
    Nieto-Guerrero Gómez JM; Silva Vega GP; Cacicedo J; Delgado León BD; Herrero Rivera D; Praena Fernández JM; Rivin Del Campo E; Ortiz Gordillo MJ; López Guerra JL
    Clin Transl Oncol; 2020 Sep; 22(9):1635-1644. PubMed ID: 32072471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery.
    Barlési F; Doddoli C; Loundou A; Pillet E; Thomas P; Auquier P
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):548-53. PubMed ID: 16860566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study.
    Langendijk H; de Jong J; Tjwa M; Muller M; ten Velde G; Aaronson N; Lamers R; Slotman B; Wouters M
    Radiother Oncol; 2001 Mar; 58(3):257-68. PubMed ID: 11230886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study.
    Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.